Autophagy as a molecular target for cancer treatment

No Thumbnail Available

Date

2019

Journal Title

Journal ISSN

Volume Title

Publisher

Elsevier

Open Access Color

OpenAIRE Downloads

OpenAIRE Views

Research Projects

Organizational Units

Journal Issue

Abstract

Autophagy is an evolutionarily conserved catabolic mechanism, by which eukaryotic cells recycle or degrades internal constituents through membrane-trafficking pathway. Thus, autophagy provides the cells with a sustainable source of biomolecules and energy for the maintenance of homeostasis under stressful conditions such as tumor microenvironment. Recent findings revealed a close relationship between autophagy and malignant transformation. However, due to the complex dual role of autophagy in tumor survival or cell death, efforts to develop efficient treatment strategies targeting the autophagy/cancer relation have largely been unsuccessful. Here we review the two-faced role of autophagy in cancer as a tumor suppressor or as a pro-oncogenic mechanism. In this sense, we also review the shared regulatory pathways that play a role in autophagy and malignant transformation. Finally, anti-cancer therapeutic agents used as either inhibitors or inducers of autophagy have been discussed.

Description

kig, cenk/0000-0002-6318-5001; Kocaturk, Nur/0000-0002-4452-9913; Akkoc, Yunus/0000-0001-5379-6151; bayraktar ekmekcigil, oznur/0000-0002-4824-9943; Devrim, Gozuacik/0000-0001-7739-2346; Kutlu, Ozlem/0000-0002-3769-2536

Keywords

Autophagy, Cancer, Therapeutic agents

Turkish CoHE Thesis Center URL

Fields of Science

Citation

251

WoS Q

Q2

Scopus Q

Q1

Source

Annual Meeting of the European-Federation-of-Pharmaceutical-Sciences (EUFEPS) -- MAY 24-26, 2018 -- Athens, GREECE

Volume

134

Issue

Start Page

116

End Page

137